Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Birchmeier, Walter Prof. Dr. (1) Hinz, Michael Dr. (1) Janz, Martin Dr. (9) Kammertöns, Thomas Dr. (1) Kieback, Elisa Dr. (1) Kobelt, Dennis Dr. (2) Leisegang, Matthias Prof. Dr. rer. nat. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (9) Röefzaad, Claudia (1) Scheidereit, Claus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (87) Smith, Janice (2) Stein, Ulrike Prof. Dr. (13) Uckert, Wolfgang Prof. Dr. (6) Walther, Wolfgang Prof. Dr. (11) Willimsky, Gerald Dr. (2) Wollert-Wulf, Brigitte (2) (-) Blankenstein, Thomas Prof. Dr. (15) (-) Daniel, Peter Prof. Dr. (3) (-) Biologie maligner Lymphome (1) (-) Molekulare Immunologie und Gentherapie (15) Proteom Dynamik (6) Systembiologie von Gen-regulatorischen Elementen (1) (-) Translationale Onkologie solider Tumore (3) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) (-) 2003 (10) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (5) (-) 2008 (5) 2009 (2) 2010 (8) 2011 (5) 2012 (6) 2013 (11) 2014 (3) 2015 (4) 2016 (4) 2017 (7) 2018 (4) 2019 (7) 2021 (4) 2022 (6) 2023 (4) 2024 (2) 18 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Daniel, Peter Prof. Dr.Biologie maligner LymphomeMolekulare Immunologie und Gentherapie Translationale Onkologie solider Tumore200320062008 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 30. Januar 2003 / Oncogene Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice K. Lange W. Uckert T. Blankenstein R. Nadrowitz C. Bittner J.C. Renauld J. van Snick A.C. Feller H. Merz 10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel 01. Januar 2003 / Verh Dtsch Ges Pathol Die Ueberexpression von NPM-ALK in haematopoietischen Stammzellen induziert verschiedene maligne Non-Hodgkin-Lymphome in der IL-9 transgenen Maus [Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice] H. Merz K. Lange R. Nadrowitz W. Uckert T. Blankenstein A.C. Feller 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert 15. September 2003 / J Clin Oncol Dynamic expression profile of p21 WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy B. Rau I. Sturm H. Lage S. Berger U. Schneider S. Haupfmann P. Wust H. Riess P.M. Schlag B. Doerken P.T. Daniel 17. November 2003 / J Exp Med Tumor rejection by modulation of tumor stromal fibroblasts T. Schueler S. Koernig T. Blankenstein 01. Dezember 2003 / J Mol Med Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes M.D. Muehlebach I. Schmitt S. Steidl J. Stitz M. Schweizer T. Blankenstein K. Cichutek W. Uckert 01. Januar 2003 / Adv Cancer Res Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance T. Blankenstein Z. Qin 01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
30. Januar 2003 / Oncogene Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice K. Lange W. Uckert T. Blankenstein R. Nadrowitz C. Bittner J.C. Renauld J. van Snick A.C. Feller H. Merz
10. Mai 2006 / BMC Cancer Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy I. Sturm B. Rau P.M. Schlag P. Wust B. Hildebrandt H. Riess S. Hauptmann B. Doerken P.T. Daniel
01. Januar 2003 / Verh Dtsch Ges Pathol Die Ueberexpression von NPM-ALK in haematopoietischen Stammzellen induziert verschiedene maligne Non-Hodgkin-Lymphome in der IL-9 transgenen Maus [Overexpression of NPM-ALK induces different types of malignant lymphomas in IL-9 transgenic mice] H. Merz K. Lange R. Nadrowitz W. Uckert T. Blankenstein A.C. Feller
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
15. Januar 2008 / Proc Natl Acad Sci U S A A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer E. Kieback J. Charo D. Sommermeyer T. Blankenstein W. Uckert
15. September 2003 / J Clin Oncol Dynamic expression profile of p21 WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy B. Rau I. Sturm H. Lage S. Berger U. Schneider S. Haupfmann P. Wust H. Riess P.M. Schlag B. Doerken P.T. Daniel
17. November 2003 / J Exp Med Tumor rejection by modulation of tumor stromal fibroblasts T. Schueler S. Koernig T. Blankenstein
01. Dezember 2003 / J Mol Med Transduction efficiency of MLV but not of HIV-1 vectors is pseudotype dependent on human primary T lymphocytes M.D. Muehlebach I. Schmitt S. Steidl J. Stitz M. Schweizer T. Blankenstein K. Cichutek W. Uckert
01. Januar 2003 / Adv Cancer Res Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance T. Blankenstein Z. Qin
01. April 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel